Pure Tax Investigations, led by tax specialist Amit Puri, supports individuals and businesses navigating HMRC tax enquiries and voluntary disclosure procedures. London, United Kingdom – Pure Tax Investigations, a specialist
FDA Orphan Drug Designation for GENFIT’s G1090N With no approved therapy for Acute-on-Chronic Liver Failure (ACLF) and approximately 62K cases recorded across major markets, this FDA designation of GENFIT’s G1090N
Most NRIs focus on what to do—sell the car, ship belongings. But the real struggle? Missing critical steps (RNOR windows cost lakhs), disorganized information scattered everywhere, and resources you can
Psoriatic Arthritis Market Psoriatic Arthritis companies are UCB Biopharma, Sun Pharmaceutical Industries Limited, BMS, Affibody AB, Janssen Biotech, Amgen, Eli Lilly and Company, Teva Pharma, Boehringer Ingelheim, AbbVie, Roche, Ampio
TECVAYLI + DARZALEX FASPRO FDA Approval Johnson & Johnson (NYSE: JNJ)’s Phase 3 MajesTEC-3 data show an 83% reduction in risk of disease progression or death, with 83.3% of patients
SGS, the world’s leading independent testing and certification body, has issued a landmark special report on WANPY®’s premium XIAOJINDUN staple food line. The Chinese pet food brand proactively submitted all
In the recently concluded ice and snow tourism season, a surge of tourists from Southeast Asia—including Thailand and Malaysia—flocked to Harbin, Heilongjiang Province. This winter, bookings for Harbin’s ice and
FDA Grants Priority Review to ENHERTU in Post-Neoadjuvant HER2-Positive Early Breast Cancer Phase III DESTINY-Breast05 data shows a 53% reduction in invasive disease recurrence or death vs. T-DM1, redefining the
As St. Patrick’s Day approaches, green not only becomes the dominant color on streets and in alleys but also the perfect medium for office gentlemen to express their individuality and
FDA Accepts NDA for Rusfertide and Grants Priority Review in Polycythemia Vera Takeda and Protagonist Therapeutics’ first-in-class hepcidin mimetic moves closer to market as FDA sets Q3 2026 PDUFA date;
Minimally Invasive Surgical Devices Market Leading minimally invasive surgical devices companies include Abbott, Olympus, Intuitive Surgical Inc., Stryker, JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES, Medtronic, Boston Scientific Corporation, CONMED Corporation,
Positron Emission Tomography Market Positron emission tomography companies include General Electric Company, Bruker Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, Positron Corporation, Shimadzu Corp., RefleXion, CMR
Peripheral T-Cell Lymphoma Market Leading companies developing Peripheral T-cell Lymphoma treatments include Eisai, Celgene Corporation, HUYA Bioscience International/Quintiles, Verastem, BeiGene, Merck Sharp & Dohme Corp, Solasia Pharma, Aileron Therapeutics, Incyte,
Psychosis in Parkinson’s and Alzheimer’s Disease Market Key Psychosis in Parkinson’s and Alzheimer’s Disease Companies are Karuna Therapeutics, Sunovion Pharmaceuticals, Intra-Cellular Therapies, Acadia Pharmaceuticals, and others DelveInsight has launched a
Richardson, TX – When the FIFA World Cup kicks off this June, millions of fans across the Dallas–Fort Worth metroplex will be looking for the perfect place to experience it. At
DelveInsight’s, “Advanced Ovarian Cancer Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Advanced Ovarian Cancer pipeline landscape. It covers the Advanced Ovarian Cancer
DelveInsight’s, “Advanced Melanoma Pipeline Insight 2026” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Advanced Melanoma pipeline landscape. It covers the Advanced Melanoma pipeline drug profiles,
DelveInsight’s “Advanced Liver Cancer Pipeline Insights 2026” Report provides comprehensive insights about 50+ companies and 52+ pipeline drugs in the advanced liver cancer pipeline landscape. It covers the pipeline drug
DelveInsight “Advanced Hepatocellular Carcinoma Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Advanced Hepatocellular Carcinoma pipeline landscape. It covers the Advanced Hepatocellular
DelveInsight’s, “Advanced Gastric Carcinoma Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Advanced Gastric Carcinoma pipeline landscape. It covers the Advanced Gastric Carcinoma
